| Literature DB >> 33544916 |
Xavier Fritel1, Eleanor van den Heuvel2, Adrian Wagg3, Stéphanie Ragot1, Cara Tannenbaum4.
Abstract
AIMS: Our goal was to identify which women participating in an educational workshop on incontinence were most likely to benefit from it.Entities:
Keywords: ageing; educational workshop; urinary incontinence
Mesh:
Year: 2021 PMID: 33544916 PMCID: PMC8247852 DOI: 10.1002/nau.24614
Source DB: PubMed Journal: Neurourol Urodyn ISSN: 0733-2467 Impact factor: 2.696
Figure 1Changes in ICIQ‐FLUTS scores between baseline and follow‐up (dotted line for the minimal clinically important difference, MCID, −3.19). Negative change reflects improvement in continence. ICIQ‐FLUTS, International Consultation on Incontinence Questionnaire‐Female Lower Urinary Tract Symptoms; MCID, minimum clinical difference
Figure 2Changes in I‐QOL scores between baseline and follow‐up (dotted line for the minimal clinically important difference, MCID, +4.74). Positive change reflects improvement in Quality of Life (QoL)
Factors associated with the Patient's Global Impression of Improvement at follow‐up (“much better” or “very much better” according to PGI‐I)
| Improved | Maximal model | Final model | |||
|---|---|---|---|---|---|
| Characteristics |
| %, or mean ( | Adjusted OR (95% CI) | Adjusted OR (95% CI) | |
| Center | Montréal, Québec | 191 | 15.7 | 1 | 1 |
| Edmonton, Alberta | 46 | 10.9 | 0.78 (0.22–2.70) | 0.75 (0.23–2.46) | |
| Uxbridge, UK | 85 | 15.3 | 0.96 (0.32–2.90) | 0.96 (0.32–2.85) | |
| Poitiers, France | 70 | 18.6 | 1.84 (0.61–5.54) | 1.34 (0.47–3.78) | |
| Believe that incontinence is a normal part of ageing at baseline/follow‐up | No/no or yes | 83 | 16.9 | 2.83 (1.10–7.25) | 2.91 (1.15–7.36) |
| Yes/no | 50 | 20.0 | 3.35 (1.18–9.55) | 3.45 (1.27–9.40) | |
| Yes/yes | 141 | 6.4 | 1 | 1 | |
| Self‐reported health status | Excellent or very good | 123 | 21.1 | 1 | |
| Good | 187 | 12.8 | 0.45 (0.18–1.12) | ||
| Fair or poor | 81 | 13.6 | 0.61 (0.20–1.82) | ||
| Depression | Yes | 88 | 9.1 | 0.36 (0.10–1.34) | |
| No | 304 | 17.4 | 1 | ||
| Improvement in urinary symptoms (ICIQ‐FLUTS score) | −4.2 (5.0) | −6.6 (5.8) | 1.10 (1.00–1.20) | 1.12 (1.04–1.21) | |
| Improvement in HRQoL (I‐QoL score) | +10.4 (14.7) | +14.8 (13.3) | 1.02 (0.99–1.05) | ||
| c‐index | 0.75 | 0.72 | |||
Note: The following variables were not significant (p > .10) in the univariate analysis and were not introduced into the maximal multivariate model: smoking, education level, high blood pressure, diabetes, constipation, incontinence duration, fecal incontinence, daily coffee or tea, age, BMI, I‐QoL at baseline, ICIQ‐FLUTS at baseline, Kegel exercises at baseline/follow‐up, and falls. The final model retained only significant variables after backward elimination.
Abbreviations: BMI, body mass index; CI, confidence interval; ICIQ‐FLUTS, International Consultation on Incontinence Questionnaire‐Female Lower Urinary Tract Symptoms; I‐QoL, incontinence quality of life; OR, odds ratio; PGI‐I, Patient Global Impression of Improvement.
Response unavailable for the first women included.
OR was calculated for an improvement of the score of 1 point, that is, a variation between baseline and follow‐up equal to −1 for ICIQ‐FLUTS and + 1 for I‐QoL.
Factors associated with significant improvement in urinary symptoms (change in ICIQ‐FLUTS score ≤ −3.15). Maximal and final multivariate logistic regression
| Improved | Maximal model | Final model | |||
|---|---|---|---|---|---|
| Characteristics |
| % | Adjusted OR (95% CI) | Adjusted OR (95% CI) | |
| Center | Montréal, Québec | 191 | 56.5 | 1 | 1 |
| Edmonton, Alberta | 46 | 63.0 | 1.49 (0.72–3.06) | 1.43 (0.70–2.93) | |
| Uxbridge, UK | 85 | 55.3 | 1.59 (0.87–2.91) | 1.58 (0.87–2.88) | |
| Poitiers, France | 70 | 45.7 | 0.73 (0.40–1.35) | 0.74 (0.40–1.35) | |
| BMI (kg/m²) | −18.5 | 8 | 75.0 | 2.54 (0.44–14.59) | 2.36 (0.42–13.18) |
| 18.5–24 | 142 | 52.8 | 1 | 1 | |
| 25–29 | 138 | 48.6 | 0.79 (0.48–1.31) | 0.77 (0.47–1.26) | |
| +30 | 94 | 68.1 | 1.92 (1.06–3.48) | 1.79 (1.01–3.20) | |
| Urinary symptoms (ICIQ‐FLUTS | 1st tertile: ≤ 12.0 | 146 | 39.0 | 1 | 1 |
| 2nd tertile: 12.1–17.0 | 135 | 57.8 | 2.65 (1.51–4.64) | 2.31 (1.36–3.92) | |
| 3rd tertile: > 17.0 | 111 | 73.0 | 5.35 (2.73–10.49) | 4.36 (2.41–7.86) | |
| HRQoL (I‐QoL) at baseline | 3rd tertile: ≥ 88.6 | 137 | 51.1 | 1 | |
| 2nd tertile: 76.2–88.5 | 129 | 51.9 | 0.72 (0.41–1.25) | ||
| 1st tertile: < 76.2 | 126 | 62.7 | 0.65 (0.34–1.21) | ||
| Kegel exercises at baseline/follow‐up | Yes/no or yes | 184 | 51.1 | 1 | 1 |
| No/yes | 113 | 66.4 | 1.96 (1.15–3.31) | 1.93 (1.15–3.26) | |
| No/no | 92 | 48.9 | 1.19 (0.68–2.07) | 1.17 (0.67–2.04) | |
| c‐index | 0.70 | 0.70 | |||
Note: The following variables were not significant (p > .10) in the univariate analysis and were not introduced into the maximal multivariate model: smoking, education level, health situation, high blood pressure, diabetes, falls, belief that incontinence is a normal part of ageing at baseline/follow‐up, constipation, incontinence duration, fecal incontinence, daily coffee or tea every day, age, and depression. The final model contained only significant variables after backward elimination.
Abbreviations: BMI, body mass index; CI, confidence interval; ICIQ‐FLUTS, International Consultation on Incontinence Questionnaire‐Female Lower Urinary Tract Symptoms; I‐QoL, incontinence quality of life; OR, odds ratio; PGI‐I, Patient Global Impression of Improvement.
The higher the ICIQ‐FLUTS score (between 0 and 48), the more severe the urinary symptoms.
The higher the I‐QOL score (between 0 and 100), the better the quality of life.
Factors associated with significant improvement in urinary quality of life (change in I‐QoL score ≥ + 4.74). Maximal and final multivariate logistic regressions
| Improved | Maximal model | Final Model | |||
|---|---|---|---|---|---|
| Characteristics |
| % | Adjusted OR (95% CI) | Adjusted OR (95% CI) | |
| Center | Montréal, Québec | 191 | 67.0 | 1 | 1 |
| Edmonton, Alberta | 46 | 71.7 | 1.33 (0.58–3.03) | 1.32 (0.58–2.99) | |
| Uxbridge, UK | 85 | 60.0 | 1.08 (0.57–2.05) | 0.99 (0.53–1.85) | |
| Poitiers, France | 70 | 42.9 | 0.31 (0.16–0.60) | 0.32 (0.16–0.61) | |
| Age | 1st tertile: ≤ 72 | 125 | 64.8 | 1 | 1 |
| 2nd tertile: 73–80 | 128 | 67.2 | 1.02 (0.55–1.88) | 1.04 (0.57–1.91) | |
| 3rd tertile: ≥ 81 | 139 | 54.0 | 0.52 (0.28–0.94) | 0.53 (0.29–0.95) | |
| Urinary symptoms (ICIQ‐FLUTS) at baseline | 1st tertile: ≤ 12.0 | 146 | 46.6 | 1 | |
| 2nd tertile: 12.1–17.0 | 135 | 68.1 | 1.44 (0.79–2.62) | ||
| 3rd tertile: > 17.0 | 111 | 73.9 | 1.16 (0.58–2.33) | ||
| HRQoL (I‐QoL) at baseline | 3rd tertile: ≥ 88.6 | 137 | 31.4 | 1 | 1 |
| 2nd tertile: 76.2–88.5 | 129 | 69.8 | 5.58 (3.15–9.91) | 6.02 (3.45–10.51) | |
| 1st tertile: < 76.2 | 126 | 86.5 | 13.17 (6.43–26.99) | 14.18 (7.42–27.09) | |
| c‐index | 0.81 | 0.80 |
Note: The following variables were not significant (p > .10) in the univariate analysis and were not introduced into the maximal multivariate model: smoking, education level, health situation, high blood pressure, diabetes, falls, belief that incontinence is a normal part of ageing at baseline/follow‐up, constipation, incontinence duration, fecal incontinence, daily coffee or tea every day, BMI, depression, Kegel exercises at baseline/follow‐up. The final model contained only significant variables after backward elimination.
Abbreviations: BMI, body mass index; CI, confidence interval; ICIQ‐FLUTS, International Consultation on Incontinence Questionnaire‐Female Lower Urinary Tract Symptoms; I‐QoL, incontinence quality of life; OR, odds ratio; PGI‐I, Patient Global Impression of Improvement.
The higher the ICIQ‐FLUTS score (between 0 and 48), the more severe the urinary symptoms.
The higher the I‐QOL score (between 0 and 100), the better the quality of life.